LXRX
LXRX
US5288723027
Lexicon Pharmaceuticals, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 49.803.000 31.081.000
60.2%
Cost of Revenue 274.000 616.000
55.5%
Gross Profit 49.529.000 30.465.000
62.6%
98.440.000 227.582.000
56.7%
Operating Income -48.911.000 -197.117.000
75.2%
Pretax Income -50.341.000 -200.403.000
74.9%
Net Income Common Stockholders -50.341.000 -200.403.000
74.9%
-- --
--
-- --
--
ende